Journal: Nucleic Acids Research
Article Title: Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein
doi: 10.1093/nar/gkaa1198
Figure Lengend Snippet: Engineering of CASANOVA-C3, a light-switchable anti-CRISPR protein for optogenetic control of Nme Cas9. ( A ) Schematic of CASANOVA-C3 function. ( B ) Structure of AcrIIC3. The nine regions chosen for LOV2 domain insertion (R1–R9) are shown in red (PDB 6J9N). ( C ) Luciferase reporter-based screen of AcrIIC3-LOV2 hybrids. HEK293T cells were co-transfected with vectors encoding (i) a firefly luciferase reporter, (ii) Nme Cas9 and a sgRNA targeting the luciferase reporter and (iii) either wild-type AcrIIC3 (AcrIIC3) or the indicated AcrIIC3-LOV2 hybrid (S11-V100) followed by luciferase assay. The AcrIIC3 residues behind which the LOV2 domain was inserted are indicated. R1–9 correspond to the different regions in B. R, region. Rep, reporter only control. The lead region is labelled in bold. ( D ) Lead panel of AcrIIC3-LOV2 hybrids. Glycine–serine linkers are in green. ( E ) Luciferase assay screen of the AcrIIC3-LOV2 hybrids in D. Cells were transfected as in C and then exposed to blue light or kept in the dark for 48 hours, followed by luciferase assay. Rep, reporter only control. ( F ) HEK293T cells were co-transfected with vectors encoding (i) Nme Cas9 and a sgRNA targeting the endogenous IL2RG locus and (ii) the indicated Acr variant in D. Samples were exposed to blue light or kept in the dark for 72 h. Gene editing was assessed by T7 assay. Representative gel images are shown below the bar charts. The dotted line separates different gels. In, input. T7, T7 cleavage fragments. (C, E, F) Bars represent mean values, error bars the standard deviation and dots individual data points from n = 3 independent experiments.
Article Snippet: AcrIIC3-LOV2 hybrid constructs were created by inserting the LOV2 domain into our published CMV promoter-driven AcrIIC3 expression vector (Addgene plasmid #120301) ( ).
Techniques: CRISPR, Luciferase, Transfection, Variant Assay, Standard Deviation